Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives

Publication interest in cannabinoids, including phytocannabinoids, endogenous cannabinoids, synthetic cannabinoids and cannabinomimetic compounds, is due to the therapeutic potential of these compounds in inflammatory pathology. Since recent years, scientific interest was focused on compounds with c...

Full description

Saved in:
Bibliographic Details
Main Authors: Oksana Yu. Kytikova, Yulia K. Denisenko, Tatyana P. Novgorodtseva, Ivan S. Kovalenko
Format: Article
Language:English
Published: Limited liability company «Science and Innovations» (Saratov) 2023-03-01
Series:Russian Open Medical Journal
Subjects:
Online Access:https://romj.org/node/517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735068008841216
author Oksana Yu. Kytikova
Yulia K. Denisenko
Tatyana P. Novgorodtseva
Ivan S. Kovalenko
author_facet Oksana Yu. Kytikova
Yulia K. Denisenko
Tatyana P. Novgorodtseva
Ivan S. Kovalenko
author_sort Oksana Yu. Kytikova
collection DOAJ
description Publication interest in cannabinoids, including phytocannabinoids, endogenous cannabinoids, synthetic cannabinoids and cannabinomimetic compounds, is due to the therapeutic potential of these compounds in inflammatory pathology. Since recent years, scientific interest was focused on compounds with cannabinomimetic activity. The therapeutic use of phytocannabinoids and endocannabinoids is somewhat limited due to unresolved issues of dosing, toxicity and safety in humans, while cannabinoid-like compounds combine similar therapeutic effects with a high confirmed safety. Targets for endocannabinoids and phytocannabinoids are endocannabinoid receptors 1 and 2, G protein-coupled receptors (GPCRs), peroxisome proliferator-activated receptors (PPARs), and transient receptor potential ion channels (TRPs). Non-endocannabinoid N-acylethanolamines do not interact with cannabinoid receptors and exhibit agonist activity towards non-cannabinoid receptors, such as PPARs, GPCRs and TRPs. This literature review includes contemporary information on the biological activity, metabolism and pharmacological properties of cannabinoids and cannabinoid-like compounds, as well as their receptors. We established that only a few studies were devoted to the relationship of non-endocannabinoid N-acylethanolamines with non-cannabinoid receptors, such as PPARs, GPCRs, and also with TRPs. We have focused on issues that were insufficiently covered in the published sources in order to identify gaps in existing knowledge and determine the prospects for scientific research.
format Article
id doaj-art-3cb46267db1844fcb9d046a36ff1ac0e
institution DOAJ
issn 2304-3415
language English
publishDate 2023-03-01
publisher Limited liability company «Science and Innovations» (Saratov)
record_format Article
series Russian Open Medical Journal
spelling doaj-art-3cb46267db1844fcb9d046a36ff1ac0e2025-08-20T03:07:38ZengLimited liability company «Science and Innovations» (Saratov)Russian Open Medical Journal2304-34152023-03-01121e010710.15275/rusomj.2023.0107Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectivesOksana Yu. KytikovaYulia K. DenisenkoTatyana P. NovgorodtsevaIvan S. KovalenkoPublication interest in cannabinoids, including phytocannabinoids, endogenous cannabinoids, synthetic cannabinoids and cannabinomimetic compounds, is due to the therapeutic potential of these compounds in inflammatory pathology. Since recent years, scientific interest was focused on compounds with cannabinomimetic activity. The therapeutic use of phytocannabinoids and endocannabinoids is somewhat limited due to unresolved issues of dosing, toxicity and safety in humans, while cannabinoid-like compounds combine similar therapeutic effects with a high confirmed safety. Targets for endocannabinoids and phytocannabinoids are endocannabinoid receptors 1 and 2, G protein-coupled receptors (GPCRs), peroxisome proliferator-activated receptors (PPARs), and transient receptor potential ion channels (TRPs). Non-endocannabinoid N-acylethanolamines do not interact with cannabinoid receptors and exhibit agonist activity towards non-cannabinoid receptors, such as PPARs, GPCRs and TRPs. This literature review includes contemporary information on the biological activity, metabolism and pharmacological properties of cannabinoids and cannabinoid-like compounds, as well as their receptors. We established that only a few studies were devoted to the relationship of non-endocannabinoid N-acylethanolamines with non-cannabinoid receptors, such as PPARs, GPCRs, and also with TRPs. We have focused on issues that were insufficiently covered in the published sources in order to identify gaps in existing knowledge and determine the prospects for scientific research.https://romj.org/node/517n-acylethanolamineanandamideoleoylethanolaminepalmitoylethanolaminedelta(δ)9-tetrahydrocannabinolcannabidiolgpcrspparstrps
spellingShingle Oksana Yu. Kytikova
Yulia K. Denisenko
Tatyana P. Novgorodtseva
Ivan S. Kovalenko
Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
Russian Open Medical Journal
n-acylethanolamine
anandamide
oleoylethanolamine
palmitoylethanolamine
delta(δ)9-tetrahydrocannabinol
cannabidiol
gpcrs
ppars
trps
title Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
title_full Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
title_fullStr Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
title_full_unstemmed Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
title_short Cannabinoids and cannabinoid-like compounds: Biochemical characterization and pharmacological perspectives
title_sort cannabinoids and cannabinoid like compounds biochemical characterization and pharmacological perspectives
topic n-acylethanolamine
anandamide
oleoylethanolamine
palmitoylethanolamine
delta(δ)9-tetrahydrocannabinol
cannabidiol
gpcrs
ppars
trps
url https://romj.org/node/517
work_keys_str_mv AT oksanayukytikova cannabinoidsandcannabinoidlikecompoundsbiochemicalcharacterizationandpharmacologicalperspectives
AT yuliakdenisenko cannabinoidsandcannabinoidlikecompoundsbiochemicalcharacterizationandpharmacologicalperspectives
AT tatyanapnovgorodtseva cannabinoidsandcannabinoidlikecompoundsbiochemicalcharacterizationandpharmacologicalperspectives
AT ivanskovalenko cannabinoidsandcannabinoidlikecompoundsbiochemicalcharacterizationandpharmacologicalperspectives